Advanced Search

 

Study ID Status Title Patient Level Data
29060/109 Completed A double-blind, short-term comparison of paroxetine and amitriptyline with a 12-month, rater-blind maintenance phase comparing paroxetine, amitriptyline and lithium in the prevention of depressive relapse in patients with major depression, recurrent.
29060/110 Completed A double-blind, placebo-controlled study to assess the effects of paroxetine on the bleeding time of healthy volunteers
29060/112 Completed A double-blind, multicentre study to compare the effectiveness and tolerance of paroxetine versus fluvoxamine in depressed patients
29060/113 Completed An open study to investigate the effects of repeated dosing of paroxetine (20 mg od for 20 days) on the pharmacokinetics and metabolism of a single dose of desipramine (100 mg) in healthy volunteer subjects.
29060/115 Completed A multicenter, randomized, double-blind, placebo-controlled comparison of paroxetine and fluoxetine in the treatment of major depressive disorder. Study Listed on ClinicalStudyDataRequest.com
29060/116 Completed Paroxetine versus Placebo in the Treatment of Obsessive-Compulsive Disorder Study Listed on ClinicalStudyDataRequest.com
29060/118 Completed Paroxetine versus Clomipramine and Placebo in the Treatment of Obsessive-Compulsive Disorder Study Listed on ClinicalStudyDataRequest.com
29060/120 Completed A double-blind, placebo-controlled, multicenter study of fixed doses of paroxetine (10, 20, and 40 mg) given as a single oral dose daily, in the treatment of panic disorder. Study Listed on ClinicalStudyDataRequest.com
29060/121 Completed A repeat-dose steady-state crossover evaluation of the bioequivalence of a tablet formulation (20 mg marketing formulation, CIDRA) and a capsule formulation (10 mg CT capsule P47) of paroxetine
29060/121/126/262 Completed The Short Term Phase of an Open, Long Term Study of Paroxetine in Elderly Patients Suffering from Depression
29060/122 Completed An Interim Report on the Short-term Phase of a Long-term Phase II Open Study to Evaluate Tolerance and Safety of Paroxetine Treatment of Depressive States (a final report was not issued).
29060/125 Completed A double-blind, placebo-controlled study to assess the effects of paroxetine on the bleeding time and prothrombin time of volunteers receiving warfarin therapy
29060/126 Completed Long-term Treatment with Paroxetine of Outpatients with Obsessive-Compulsive Disorder. An Extension of the Fixed-Dose Study (Study 116).
29060/127 Completed Long-term treatment with paroxetine of outpatients with obsessive-compulsive disorder: An extension of the companion study.
29060/128 Completed A Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison of Paroxetine and Fluoxetine in the Treatment of Major Depressive Disorder Study Listed on ClinicalStudyDataRequest.com
29060/131 Completed A Double-Blind, Randomized, Multicentre Comparison of Paroxetine and Fluoxetine in the Treatment of Patients With Major Depression With Regard to Antidepressant Efficacy, Tolerance and Anxiolytic Effect
29060/134 Completed A randomized, double-blind, controlled study of paroxetine and fluoxetine in the treatment of patients with major depression with associated anxiety. Extensive searching has revealed that no clinical study report is available for this study.
29060/135 Completed A Comparative Double-Blind Study of Paroxetine and Fluoxetine in the Treatment of Depression in Out-Patients
29060/136 Completed A Double-Blind Study to Assess the Efficacy and Tolerance of a Flexible Dose of Paroxetine Compared with a Flexible Dose of Clomipramine and Placebo in the Treatment of Obsessive Compulsive Disorder. Study Listed on ClinicalStudyDataRequest.com
29060/139 Completed A study of the pharmacokinetics of paroxetine after single oral doses of BRL 29060A
29060/140 Completed Double-blind tolerance study of 30 mg of paroxetine
29060/141 Completed A comparison of the pharmacokinetics of paroxetine after a single oral dose before and after 30 days of once daily oral administration
29060/142 Completed A study to assess the CNS effects of paroxetine and any interaction with the sedative effects of amylobarbitone
29060/143 Completed A study to assess the effect of repeat dosing with paroxetine 30 mg once daily on the pharmacokinetics of phenytoin in healthy male volunteers
29060/144 Completed Pharmacokinetic profile of antipyrine before and after the administration of paroxetine

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.